Company: SXTPW
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001213900-25-008463
Chunk: 0

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement.

On
January 28, 2025, 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (the “ Company”),
entered into a securities purchase agreement (the “ Securities Purchase Agreement”)
with certain institutional investors (the “ Purchasers”) pursuant to which the
Company sold, in a registered direct offering an aggregate of 1,021,549 shares (the “ Shares”)
of common stock, par value $0.0001 per share, of the Company (“ Common Stock”)
at a purchase price of $1.021 per share in a registered direct offering priced at-the-market
under the rules of The Nasdaq Stock Market LLC.

The
Shares were offered pursuant to a “shelf” registration statement on Form S-3 (Registration No. 333-280796), which was declared
effective by the Securities and Exchange Commission (the “ SEC”) on July 18, 2024 as supplemented by a prospectus supplement
dated January 28, 2025, filed with the SEC on January 30, 2025, and accompanying base prospectus, pursuant to Rule 424(b)(5) promulgated
under the Securities Act of 1933, as amended (the “ Securities Act”).

In
a concurrent private placement, the Company also issued to the Purchasers unregistered warrants
(the “ Warrants”) to purchase up to an aggregate of 2,043,098 shares (the “ Warrant
Shares”) of Common Stock at an exercise price of $0.771 per share. The Warrants are
exercisable upon issuance and expire twenty-four months from the date of issuance.

Pursuant
to the Securities Purchase Agreement, the Company is required to file a registration statement with the SEC within 45 days after the
date of the Securities Purchase Agreement to register the Warrant Shares under the Securities Act. The Company shall use commercially
reasonable efforts to cause such registration statement to become effective within 75 days following the Closing Date and to keep such
registration statement effective at all times until no Purchaser owns any Warrants or Warrant Shares issuable upon exercise thereof.

Any
holder will not have the right to exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially
own more than 4.99% (or, upon the election of the holder, 9.99%) of the number of shares of the Common Stock outstanding immediately